comparemela.com
  1. Home
  2. Live Updates
  3. Zenshine Pharmaceuticals ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults : comparemela.com

Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults

Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Nanjing ,Jiangsu ,China ,Shanghai ,Chinese ,Jinfu Yang ,Wenhong Zhang ,National Center ,Fudan University ,Zenshine Pharmaceuticals Co Ltd ,Zenshine Pharmaceuticals ,First Infection Collaboration Forum ,Chinese National Center ,Infectious Diseases ,Professor Jing Zhang ,Huashan Hospital ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.